Back to Search
TANYA HANKE, DO
DO
Family Medicine Physician
NPI: 1760644082IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
51121(CT)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE
Class of 2008
Research & Publications (20)
The effect of biventricular pacing on cardiac function after weaning from cardiopulmonary bypass in patients with reduced left ventricular function: a pressure-volume loop analysis.
PMID 19577072·J Thorac Cardiovasc Surg·2009
8-other
STEP trial and HIV-1 vaccines inducing T-cell responses.
PMID 18393600·Expert Rev Vaccines·2008
6-review
Autograft regurgitation and aortic root dimensions after the Ross procedure: the German Ross Registry experience.
PMID 17846313·Circulation·2007
4-observational
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
PMID 17170430·J Gen Virol·2007
6-review
Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial.
PMID 16432028·J Gen Virol·2006
7-preclinical
Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
PMID 15670887·Vaccine·2005
7-preclinical
Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.
PMID 15659754·J Gen Virol·2005
4-observational
Prospects for an effective T cell-based immunoprophylaxis against mother-to-child transmission of HIV-1.
PMID 15373343·Folia Biol (Praha)·2004
6-review
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
PMID 15039533·J Gen Virol·2004
3-trial
Development of prophylactic AIDS vaccines: the current state of affairs.
PMID 12669467·Curr Opin Mol Ther·2003
6-review
Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
PMID 12560568·J Gen Virol·2003
7-preclinical
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.
PMID 12533717·J Gen Virol·2003
7-preclinical
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.
PMID 11752703·J Gen Virol·2002
7-preclinical
Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
PMID 12443668·Vaccine·2002
7-preclinical
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
PMID 11514732·J Gen Virol·2001
7-preclinical
Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responses.
PMID 11899238·Curr Mol Med·2001
6-review
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
PMID 10973301·Nat Med·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16 COMMUNITY LN
SOUTHWEST HARBOR, ME 04679 - Phone
- (207) 285-6324
Quick Facts
- NPI
- 1760644082
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile